Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing

• DOI: 10.1016/j.hrcr.2017.07.009
• Publication Date: 2017-08-01T12:45:10Z
• Authors: Paola Berne; Graziana Viola; Giovanni Motta; Nicola Marziliano; Valerio Carboni; Gavino Casu
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Catecholaminergic polymorphic ventricular tachycardia; Device repositioning; Inappropriate shock delivery; Myopotential oversensing; Subcutaneous defibrillator; Subcutaneous defibrillator; Catecholaminergic polymorphic ventricular tachycardia; RC666-701; Diseases of the circulatory (Cardiovascular) system; Device repositioning; Case Report; Myopotential oversensing; Inappropriate shock delivery